Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q86VU5
UPID:
CMTD1_HUMAN
Alternative names:
-
Alternative UPACC:
Q86VU5; Q8TE79
Background:
Catechol O-methyltransferase domain-containing protein 1, identified by the accession number Q86VU5, is characterized as a putative O-methyltransferase. This protein plays a crucial role in the methylation process, a biochemical reaction essential for a wide range of biological functions including the metabolism of catecholamines, which are vital for neurotransmission.
Therapeutic significance:
Understanding the role of Catechol O-methyltransferase domain-containing protein 1 could open doors to potential therapeutic strategies. Its involvement in the methylation of catecholamines suggests a significant impact on neurological processes, making it a potential target for treating disorders related to neurotransmitter imbalances.